Angela Lewandowski, Ph.D.
About Angela Lewandowski, Ph.D.
Angela Lewandowski, Ph.D., is the Director of Downstream Bioprocess Development at Bristol Myers Squibb in Greater Boston, overseeing a team of scientists and leading various initiatives in biologics process development.
Director, Downstream Bioprocess Development at Bristol Myers Squibb
Angela Lewandowski, Ph.D., currently holds the position of Director, Downstream Bioprocess Development at Bristol Myers Squibb (BMS) in Greater Boston. In this role, she oversees a team of 12 scientists and is responsible for all aspects of downstream process development, including recovery, stability/cryogenics, technology transfer, and in-process control strategies for biologics. She plays a pivotal role in the execution and management of process-related deliverables, ensuring efficient workflow and high-quality outcomes.
Career at Bristol Myers Squibb
Angela Lewandowski has a robust career at Bristol Myers Squibb, starting as Manager, Downstream Process Development from 2013 to 2016 in Devens, MA. She then served as Group Leader from 2016 to 2018 and subsequently as Associate Director from 2018 to 2020. During her tenure, she authored white papers on process characterization and viral clearance studies and led site initiatives. She also serves as a sponsor for external BioPhorum Development Group and is an active member of the cross-functional biologics specifications committee and the critical quality attributes council.
Previous Experience at Genzyme and Regeneron Pharmaceuticals
Before joining Bristol Myers Squibb, Angela Lewandowski worked at Genzyme in various capacities, including CMC Technical Lead for Campath/Lemtrada and Process/Analytical Scientist. Her tenure at Genzyme, spanning from 2008 to 2013, involved roles in late-stage purification development and manufacturing sciences and technology. Prior to Genzyme, she spent three years at Regeneron Pharmaceuticals as a Research Associate in Pre-clinical Manufacturing & Process Development, based in Tarrytown, NY.
Educational Background
Angela Lewandowski earned her Ph.D. in Chemical and Biomolecular Engineering from the University of Maryland College Park, where she also achieved her M.S. in Chemical Engineering. Prior to this, she completed her B.S. in Chemical Engineering at the University of Virginia. Her academic background has been fundamental in shaping her extensive career in bioprocess development and chemical engineering.
Contributions to Industry and Academia
Apart from her industry roles, Angela Lewandowski also contributed to academia as an Adjunct Professor in the Department of Chemical and Biological Engineering at Tufts University from 2012 to 2013. In her industry roles, she has spearheaded various initiatives and projects that contribute significantly to the field of bioprocess development. This includes her role as a matrix process development lead for a late-stage biologics program and her collaboration with Manufacturing Sciences and Technology at BMS.